K301 for the Treatment of Seborrhoeic Eczema (SE) of the Scalp

Inclusion Criteria: * Male or female (including fertile women) * 18-70 years of age * Seborrhoeic eczema of the scalp for at least 2 months * Presenting erythema and desquamation of mild to moderate intensity * Signed written informed consent Exclusion Criteria: * Seborrhoeic eczema or any other cutaneous disease of the face or scalp requiring a specific topical treatment (corticosteroids, antifungals, selenium sulphide, antibiotics, retinoids, benzoyl peroxide or a-hydroxyacids) during the previous 15 days * Oral treatment with cyclines, lithium, antifungals or inhaled corticosteroids during the previous month * Use of systemic corticosteroids and retinoids during the previous 2 months * Seborrhoeic eczema associated with Parkinson's disease or HIV infection * Current or any history of ear, nose, and throat carcinoma * Current or any history of severe concomitant disease according to Investigator's judgement * Allergy to any of the tested treatment components * Subject who has been previously enrolled in the phase II study K40-3 investigating Kaprolac® K40